Abstract:Background: N6-methyladenosine (m6A) RNA methylation modifications have been widely implicated in the metabolic reprogramming of various cell types within the tumor microenvironment (TME) and are essential for meeting the demands of cellular growth and maintaining tissue homeostasis, enabling cells to adapt to the specific conditions of the TME. An increasing number of research studies have focused on the role of m6A modifications in glucose, amino acid and lipid metabolism, revealing their capacity to induce aberrant changes in metabolite levels. These changes may in turn trigger oncogenic signaling pathways, leading to substantial alterations within the TME. Notably, certain metabolites, including lactate, succinate, fumarate, 2-hydroxyglutarate (2-HG), glutamate, glutamine, methionine, S-adenosylmethionine, fatty acids and cholesterol, exhibit pronounced deviations from normal levels. These deviations not only foster tumorigenesis, proliferation and angiogenesis but also give rise to an immunosuppressive TME, thereby facilitating immune evasion by the tumor. Aim of review: The primary objective of this review is to comprehensively discuss the regulatory role of m6A modifications in the aforementioned metabolites and their potential impact on the development of an immunosuppressive TME through metabolic alterations. Key scientific concepts of review: This review aims to elaborate on the intricate networks governed by the m6A-metabolite-TME axis and underscores its pivotal role in tumor progression. Furthermore, we delve into the potential implications of the m6A-metabolite-TME axis for the development of novel and targeted therapeutic strategies in cancer research.

Interplay between the m6A Epitranscriptome and Tumor Metabolism: Mechanisms and Therapeutic Implications

Interaction Between N6-methyladenosine Modification and the Tumor Microenvironment in Colorectal Cancer

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Interplay Between M6a RNA Methylation and Regulation of Metabolism in Cancer

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Functions of N6-methyladenosine in Cancer Metabolism: from Mechanism to Targeted Therapy

The role of m6A RNA methylation in cancer metabolism

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

The Roles of M6a RNA Modifiers in Human Cancer

Intertwined Regulation Between RNA M6a Modification and Cancer Metabolism

m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism

Link Between M6a Modification and Cancers

Function of N6-Methyladenosine Modification in Tumors

The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing

N6-methyladenosine-dependent Signalling in Cancer Progression and Insights into Cancer Therapies

N6-methyladenosine links RNA metabolism to cancer progression

The Role of RNA M6a Modification in Cancer Glycolytic Reprogramming

Mechanisms of N6‑methyladenosine Modification in Tumor Development and Potential Therapeutic Strategies (Review)

N 6 ‐methyladenosine Steers RNA Metabolism and Regulation in Cancer

N6-methyladenosine (m6a) RNA Modification in Tumor Immunity

Abnormal changes in metabolites caused by m6A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application